IGF2BP3 and hepatocellular carcinoma: To determine whether IGF2BP3 regulates the NF1 expression via m6A‐dependent manner, we conducted a dual‐luciferase assay in MDA‐MB‐231 and HCC‐1806 cells to identify the m6A sites that were necessary for the IGF2BP3 binding to NF1 mRNA.